Last week, the World Health Organization launched a multinational clinical trial to investigate four potential coronavirus treatments, including the malaria drug hydroxychloroquine. Meanwhile, some pharmaceutical companies and start-ups, including several in the Bay Area, are also initiating trials. We’ll talk about the status of efforts to find an effective COVID-19 treatment and the challenges associated with bringing a therapy to market in time to stem the pandemic.
As WHO Launches Major Coronavirus Trial, the Race for a Therapy Accelerates
Last week, the World Health Organization launched a multinational clinical trial to investigate four potential coronavirus treatments, including the malaria drug hydroxychloroquine. Meanwhile, some pharmaceutical companies and start-ups, including several in the Bay Area, are also initiating trials. We'll talk about the status of efforts to find an effective COVID-19 treatment and the challenges associated with bringing a therapy to market in time to stem the pandemic.
28:44
Geneva, Switzerland - World Health Organization Headquarters Building (mseidelch/iStock )
Guests:
Jon Cohen, staff writer, Science
Dr. Annie Luetkemeyer, professor of medicine and infectious diseases specialist, UCSF